NCT06248268 Neuropsychological Patterns of Suicide Ideators and Suicide Attempters
| NCT ID | NCT06248268 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Bern |
| Condition | Inhibitory Control |
| Study Type | OBSERVATIONAL |
| Enrollment | 180 participants |
| Start Date | 2024-08-08 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 180 participants in total. It began in 2024-08-08 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The present study consists of 3 projects in total and aims to investigate the (neuro-) psychological patterns from suicidal ideation to suicidal behavior as well as the effects and feasibility of ASSIP Home Treatment. The overall aim of project 1 is to determine (neuro-) psychological differences between suicide attempters, suicide ideators, a clinical control group, and healthy controls. Study participants in project 1 will participate in a one-time (neuro-) psychological assessment. Project 1 of this study is an observational cross-sectional study with four groups that will be conducted at the University Hospital of Psychiatry and Psychotherapy Bern (Switzerland): Patients with at least one suicide attempt in their past (SUAT), patients with suicidal ideation (SUID), patients from the same clinical cohort, without neither suicidal behavior or ideation (CLIN) and the healthy group (HLTH). The cohorts to be examined (SUAT \& SUID) will be compared to the two control groups (CLIN \& HLTH). Only people who have signed the informed consent and meet the eligibility criteria can participate in this study.
Eligibility Criteria
Inclusion Criteria: Subjects fulfilling the following inclusion criteria are eligible for the study: * Informed consent as documented by signature * Age ≥ 18 years Additional inclusion criterion for the SUAT group in project 1: • At least one previous suicide attempt Additional inclusion criterion for the SUID group in project 1: • Suicidal ideation Additional inclusion criterion for the CLIN group in project 1: • Current psychiatric disorder treated on an inpatient, day-care or outpatient basis For the HLTH group, no further inclusion criteria are formulated. Exclusion Criteria: The presence of any one of the following exclusion criteria leads to exclusion of the subject: * Serious cognitive impairment * Any current psychotic disorder * Any current medication, which substantially impairs the attention span, reaction rate or any other relevant cognitive functions * Inability to follow the procedures of the study (e.g., insufficient mastery of the German language, previous enrolment into the current study) Additional exclusion criterion for the SUID group: • Previous suicidal behavior Additional exclusion criteria for the CLIN and HLTH groups: * Previous suicidal behavior * Suicidal ideation Additional exclusion criterion for the HLTH group: • Current psychiatric disorder treated on an inpatient, day-care or outpatient basis
Contact & Investigator
Anja C. Gysin-Maillart, PD Dr. phil.
PRINCIPAL INVESTIGATOR
University of Bern, University Hospital of Psychiatry, Translational Research Center
Frequently Asked Questions
Who can join the NCT06248268 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Inhibitory Control. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06248268 currently recruiting?
Yes, NCT06248268 is actively recruiting participants. Contact the research team at anja.gysin-maillart@unibe.ch for enrollment information.
Where is the NCT06248268 trial being conducted?
This trial is being conducted at Bern, Switzerland.
Who is sponsoring the NCT06248268 clinical trial?
NCT06248268 is sponsored by University of Bern. The principal investigator is Anja C. Gysin-Maillart, PD Dr. phil. at University of Bern, University Hospital of Psychiatry, Translational Research Center. The trial plans to enroll 180 participants.